In SAT, the number of CD34+ cells was higher in CAD patients relative to NCAD patients (P < 0.05), whereas the number CD31+ cells did not differ significantly between the CAD and NCAD groups (P > 0.05). This evidence concerns the gene PECAM1 and coronary artery disorder.